Tumor markers, such as carcinoembryonic antigen and carbohydrate antigen 19-9, can aid in the identification and monitoring of gastric adenocarcinoma (26–28), although these markers lack sensitivity and specificity in screening for GC and are not the most effective tools for early detection (29). This evidence concerns the gene CEACAM5 and gastric cancer.